EMA backs active substance scale-up at Janssen’s COVID-19 vaccine site in the Netherlands 05-Jul-2021 By Jane Byrne The committee for human medicines (CHMP) of the European Medicines Agency (EMA) has approved a scale-up of the active substance manufacturing process at a Janssen Biologics BV site in the Netherlands.